Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Not yet recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Tubular Adenocarcinoma 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Infections 1Hemangioma, Cavernous, Central Nervous System 1Hemangioma 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Gallbladder Cancer Unresectable 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Cancer-Related Condition 1Cachexia 1Brenner Tumor 1Biliary Tract Neoplasms 1

Interventions

Rituximab 57Cyclophosphamide 40Vincristine 26Prednisone 25Doxorubicin 22Cytarabine 18Lenalidomide 17Etoposide 17Gemcitabine 12Melphalan 8Filgrastim 8Cisplatin 8zanubrutinib 7Peripheral Blood Stem Cell Transplantation 7Oxaliplatin 7N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7Methotrexate 7Ifosfamide 7Carmustine 7R-CHOP protocol 6fludarabine phosphate 5Vindesine 5Radiotherapy 5Dexamethasone 5Decitabine 5Busulfan 5ibrutinib 4Methylprednisolone 4Epirubicin 4Cyclosporine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Large B-Cell, Diffuse × Observation × Clear all
NCT03016000 2017-07-28

Thalidomide Maintenance Treatment in DLBCL

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
226 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡